Fondaparinux Sodium and Moxetumomab Pasudotox-tdfk
Determining the interaction of Fondaparinux Sodium and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fondaparinux
Brand name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose
Synonyms: Fondaparinux
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fondaparinux Sodium-Moxetumomab pasudotox-tdfk Intravenous
- Fondaparinux Sodium-Moxifloxacin
- Fondaparinux Sodium-Moxifloxacin (Systemic)
- Fondaparinux Sodium-Moxifloxacin Hydrochloride
- Fondaparinux Sodium-Moxifloxacin Injection
- Fondaparinux Sodium-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Fondaparinux Subcutaneous
- Moxetumomab Pasudotox-tdfk-Foradil
- Moxetumomab Pasudotox-tdfk-Foradil Aerolizer
- Moxetumomab Pasudotox-tdfk-Forane
- Moxetumomab Pasudotox-tdfk-Forfivo XL
- Moxetumomab Pasudotox-tdfk-Formerly available as Dalmane